Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents
1 clinical trials · Condition
◉ Watch Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935 (NCT02497235) | Takeda | 2015-07-01 |
Track Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents automatically
Every clearance here is in the API, with alerts when new ones post.